Growing community of inventors

Menlo Park, CA, United States of America

Chris Hidemi Mizufune Takimoto

Average Co-Inventor Count = 3.60

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Chris Hidemi Mizufune TakimotoMark P Chao (3 patents)Chris Hidemi Mizufune TakimotoJens-Peter Volkmer (2 patents)Chris Hidemi Mizufune TakimotoRavindra Majeti (1 patent)Chris Hidemi Mizufune TakimotoYinuo Cao (1 patent)Chris Hidemi Mizufune TakimotoKelly Tran (1 patent)Chris Hidemi Mizufune TakimotoRoy Louis Maute (1 patent)Chris Hidemi Mizufune TakimotoMark Ping Chao (0 patent)Chris Hidemi Mizufune TakimotoYinuo Cao (0 patent)Chris Hidemi Mizufune TakimotoRoy Louis Maute (0 patent)Chris Hidemi Mizufune TakimotoKelly Tran (0 patent)Chris Hidemi Mizufune TakimotoMark Ping Chao (0 patent)Chris Hidemi Mizufune TakimotoChris Hidemi Mizufune Takimoto (3 patents)Mark P ChaoMark P Chao (23 patents)Jens-Peter VolkmerJens-Peter Volkmer (30 patents)Ravindra MajetiRavindra Majeti (45 patents)Yinuo CaoYinuo Cao (1 patent)Kelly TranKelly Tran (1 patent)Roy Louis MauteRoy Louis Maute (1 patent)Mark Ping ChaoMark Ping Chao (0 patent)Yinuo CaoYinuo Cao (0 patent)Roy Louis MauteRoy Louis Maute (0 patent)Kelly TranKelly Tran (0 patent)Mark Ping ChaoMark Ping Chao (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Forty Seven, Inc. (3 from 15 patents)


3 patents:

1. 11891450 - Anti-CD47 agent-based treatment of CD20-positive cancer

2. 11802153 - Anti-CD47 agent-based ovarian cancer therapy

3. 11795223 - Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/13/2025
Loading…